 NEWARK, Calif., Oct. 30, 2020 GLOBE NEWSWIRE -- CymaBay Therapeutics, Inc. NASDAQ: CBAY, a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that it will host a conference call and live audio webcast on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time to discuss financial results for the third quarter and nine months ended September 30, 2020 and to provide a business update. 